FDA Investigator James D Bridges

James D Bridges has inspections in 5 countries as of 07 Nov 2023. James D Bridges has collaborated with a combinined 3014 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
89
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Germany, Canada, Italy, Austria
Co-Investigator(s):
Adetutu M Gidado, Alice S Tsao, Althea A Williams, Amal M Mansour, Anastasia M Shields, Anita Narula, PhD, Anita R Michael, Ann B Okon, April L Young, Arduino Frankovic, Arsen Karapetyan, Arthur G Hurst, Azza Talaat, Barbara Janine Breithaupt, Bijoy Panicker, Bo Chi, PhD, Brandon C Heitmeier, Brandy N Lepage, Brian J Ryan, Bruce G Cooper, Bruce H Mccullough, Carley R Anderson, Carolyn J Cook, Cassandra L Winters, Charanjeet Jassal, Charisse K Green, Cheryl L Manney, Christopher S Fields, Christopher T Peters, Crystal A Branch, Cynthia A Stempniak, Daniel L Aisen, David A Carlson, David A Laplante, David G Eng, David M Mcnew, David R Delucia, Diamond M Oden, Diane E Bruce, Diane L Raccasi, Dipesh K Shah, Douglas A Campbell, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elizabeth H Davis, Elizabeth H Slazak, Erika E Englund, PhD, Erin L Nagel, Evelyn Taha, Felix Maldonado, Francis A Guidry, George C Amedro, Gray, Gwyn G Dickinson, Harry J Brewer, Helen B Ricalde, Helen Verdel, Hilary K Wagner, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James I Giefer, Jay T Wong, Jazmine N Brown, Jeanette L Mcginnis, Joanne M Schlossin, Joel R Merriman, Johannes S Corley, John A Gonzalez, John A Podsadowski, Johnna L Bleem, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose O Hernandez, Joseph A Famiglietti, Joseph J Vannelli, Joseph Milcetic, Joshua D Lopez, Joy P Matthias, Joyce A Williams, Juan Rjimenez Garcia, Judy Keihl, Julie D Bringger, Julie Scoma, Junho Pak, Kalavati Suvarna, PhD, Karen A Morgante, Karen L Kosar, Kathryn A Nagy, Kellia N Hicks, Kenneth G Klobus, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kim M Downing, Kimberley A Gordon, Kimberley A Ricketts, Kimberly Y Smithson, Kyle J Spencer, Laura Fontan, MS, Lauren E Blaser, Lawrence J Stringer, LCDR Chad N Thompson, Linda M Pyias, Linda M Sacco, Manhar R Patel, Marc S Neubauer, Marcellinus D Dordunoo, Margaret M Annes, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Mark D Johnson, Marlene L Davis, Mary M Finn, Matthew D Schnittker, Michael A Charles, Michael Shanks, MS, Michael W Burd, Mindy M Chou, Morris Paul, Mra Mcculloughj, Mra Munizn, Muchael W Burd, Nancy A Saxenian Emmons, Nancy M Espinal, Nayan J Patel, Parul M Patel, Patricia A Clark, Patrick C Klotzbuecher, Patrick L Wisor, Patsy J Domingo, Paul A Bonneau, Paul Mouris, Rachael A Moliver, Rajiv R Srivastava, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard K Glabach, Robert C Coleman, Robert C Steyert, Rose M Ashley, Russ E Davis, Salvatore N Randazzo, Sangeeta M Khurana, PhD, Santos E Camara, Sasha M Latonis, Shannon A Dinardo, Simone E Pitts, Sony Mathews, State Agency, Stephen D Eich, Steven D Kehoe, Steven J Libal, Susan M Jackson, Susant Hadman, Syeda N Mahazabin, Tammy S Notto, Thomas L Bellonte, Thomas P Hansen, Tonia F Bernard, Unnee Ranjan, Wayne E Seifert, Wendy G Tan, PhD, Wendy M Stone, William C Lubas, William J Leonard, William P Chilton, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Zachary A Bogorad

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more